The cost of oncology-focused drugs in the U.S. has now exceeded $56 billion and the median annual expense of a new cancer...
NantHealth’s study data shows: Adoption of trastuzumab biosimilars in treatment of HER2-positive breast cancer is significant; does not appear to...
Recognize. Confirm. Recover. Unlike what we see in the movies, the best pilots aren’t the ones who fly their jets...
There is no doubt that COVID-19 has had a tremendous impact on the U.S. healthcare system, forcing everyone—from payers to...
The COVID-19 pandemic has highlighted many existing cracks in our healthcare system and taken a tremendous toll on the entire...
Approximately 60 percent of U.S. companies are partially or fully self-funding their health plans. With more than a third of...
The COVID-19 pandemic has abruptly and fundamentally changed our lives, with specific, evolving impacts on healthcare. Our initial responses were...
Healthcare is an ever-evolving field that continues to grow and adapt based on research, the ability to analyze data, and...
Uptown from the rubble of Ground Zero in the winter of 2002, I sorted socks, boots, and flashlight batteries in...
For payers, Eviti Connect streamlines the authorization of cancer treatment, ensuring prescription of high-quality, high-value care and setting patients on...
Over the past few months, we’ve seen a fundamental shift in healthcare. With this change comes a host of uncertainty...
As an Air Force pilot, the jets I flew all came with User’s Manuals, but unlike the one in your...
